CING
NASDAQ · Pharmaceuticals
Cingulate Inc
$5.35
+0.11 (+2.10%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+168.8% upside
Low Target
$9.95
Average Target
$14.38
High Target
$17.66
Current Price
$5.35
Current
$5.35
$5.35
Target
$14.38
$14.38
$9.95
$14.38 avg
$17.66
Scenario Analysis
Bear Case
$9.95
86.0%
Low target
Base Case
$14.38
+168.8%
Avg target
Bull Case
$17.66
+230.1%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$11.89
-55.0% from high
52-Week Low
$3.16
+69.3% from low
Target vs 52W High
$14.38
+20.9% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 38 | 79% | $1,330.33 | +13.7% |
| RDY | Strong Sell | 45 | 31% | — | +0.0% |
| JNJ | Buy | 31 | 71% | $299.55 | +11.3% |
| MRK | Buy | 36 | 72% | $159.27 | +5.5% |
| PFE | Hold | 36 | 39% | $33.90 | +21.4% |
| BMY | Hold | 35 | 43% | $174.50 | +180.3% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -38.0% |
| ZTS | Hold | 24 | 50% | $209.87 | +188.0% |